Other languages WuXi Biologics (Cayman) Inc.

Equities

2269

KYG970081173

Delayed Hong Kong S.E. Other stock markets 09:20:27 2024-06-02 pm EDT			5-day change	1st Jan Change
11.3 ^HKD	+1.44%		-4.72%	-61.82%

Jun. 01	US lawmakers ask FBI for briefing on GenScript Biotech's links to China	RE
May. 31	US lawmakers ask FBI for briefing on GenScript Biotech's links to China	RE

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

US lawmakers ask FBI for briefing on GenScript Biotech's links to China	Jun. 01
US lawmakers ask FBI for briefing on GenScript Biotech's links to China	May. 31
China stocks rise as industrial profits grow; energy, semiconductor shares lead gains	May. 27
Wuxi Biologics (Cayman) Maintains it is Not a Security Threat After House Bill Changes; Stocks Drop 3%	May. 17
US House committee advances bill to restrict BGI, WuXi AppTec	May. 15
US House committee to vote on bill to restrict BGI, WuXi AppTec	May. 15
US Congress Drafts Bill Asking Drug Firms to Unlink from Chinese Biotech Firms	May. 14
WuXi Shares Volatile as U.S. Bill Revised to Set Deadline for Decoupling	May. 13
U.S. bill to restrict WuXi AppTec, other Chinese biotech cos revised to give more time to cut ties	May. 10
Pacific Assets Trust cautiously optimistic after outpacing benchmark	Apr. 30
WuXi Biologics Cayman : Releases 2023 ESG Report Demonstrating Strong Sustainability Commitment	Apr. 30
WuXi Biologics Selected for S&P Global Sustainability Yearbook 2024	Apr. 16
WuXi Biologics Wins 2024 CDMO Leadership Awards in All Categories	Apr. 03
Wuxi Biologics Inc. Announces Retirement of Weichang Zhou as Chief Technology Officer and President of Global Biologics Development and Operations and Re-Designates as Non-Executive Director and Honorary President of Global Biologics Development and Operations and Senior Advisor to Chief Executive Officer	Apr. 01
WuXi Biologics Reports Solid 2023 Annual Results	Mar. 27
WuXi Biologics' 2023 Profit Falls 23% Despite Revenue Jump	Mar. 27
WuXi Biologics 2023 Net Profit Fell on Higher Expenses, Impairment Losses	Mar. 26
WuXi Biologics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 26
WuXi Biologics Named to CDP 'A List' for Water Security	Mar. 25
WuXi Biologics Cayman : Breaks Ground on CRDMO Center in Singapore	Mar. 19

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages WuXi Biologics (Cayman) Inc.

Equities

2269

KYG970081173

Other languages

Filters